scholarly journals A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma

Liver Cancer ◽  
2018 ◽  
Vol 7 (2) ◽  
pp. 165-178 ◽  
Author(s):  
Chia-Jui Yen ◽  
Tae-You Kim ◽  
Yin-Hsun Feng ◽  
Yee Chao ◽  
Deng-Yn Lin ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase I ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Hepatocellular Carcinoma ◽  
Asian Patients ◽  
Randomized Phase Ii

scholarly journals Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Oncology ◽  
2013 ◽  
Vol 85 (1) ◽  
pp. 44-52 ◽  
Author(s):  
Chih-Hung Hsu ◽  
Yoon Koo Kang ◽  
Tsai-Shen Yang ◽  
Chia-Tung Shun ◽  
Yu-Yun Shao ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Hepatocellular Carcinoma ◽  
First Line ◽  
First Line Therapy ◽  
Asian Patients ◽  
Multicenter Phase ◽  
Line Therapy

Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study

2016 ◽  
Vol 77 (2) ◽  
pp. 243-250 ◽  
Author(s):  
Hiroaki Nagamatsu ◽  
Shuji Sumie ◽  
Takashi Niizeki ◽  
Nobuyoshi Tajiri ◽  
Hideki Iwamoto ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hepatic Arterial Infusion ◽  
Advanced Hepatocellular Carcinoma ◽  
Arterial Infusion ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document